INFERGEN (interferon alfacon-1)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Amgen

Approval Status:

Approved October 1997

Specific Treatments:

hepatitis C

Therapeutic Areas

Immunology
Hepatology (Liver, Pancreatic, Gall Bladder)
Infections and Infectious Diseases

Find Related Trials for The Following Conditions

Hepatitis C; Chronic

General Information

A launch has taken place in the U.S. of Amgen's consensus interferon (interferon alfacon-1, INFERGEN) for the treatment of chronic hepatitis C virus infection.